Fact Check: Trump Felicit Rejects FDA Warning on Hydroxychloroquine, Politically Incorrect Claims in Study

Fact Check: Trump Felicit Rejects FDA Warning on Hydroxychloroquine, Politically Incorrect Claims in Study
Fact Check: Trump Felicit Rejects FDA Warning on Hydroxychloroquine, Politically Incorrect Claims in Study

President Donald Trump continued on Tuesday to make false and unfounded claims about hydroxychloroquine, the antimalarial drug he has repeatedly promoted and now says he is taking himself.

In a cabinet meeting on Tuesday, Trump mistook the existence of a Food and Drug Administration, warning about the use of hydroxychloroquine for coronovirus. And he claimed without any evidence that a study of veterans receiving the drug was conducted by political enemies who determined to hurt him.

A journalist reminded Trump on Tuesday that the FDA said that hydroxychloroquine should not be used outside of the hospital or in research studies.

Trump said: "No. It wasn't what I was told."

Facts First: The reporter was right. The FDA issued a safety warning on April 24, stating: "FDA warns against the use of hydroxychloroquine or chloroquine for COVID-19 outside the hospital or conducting clinical trials due to the risk of heart rhythm problems is."

We have no idea what Trump could have personally said, but it was wrong when he said "no" in response to the journalist's exact premise.

The Veterans Study.

Trump criticized a study that found no benefit of hydroxychloroquine in a group of coronovirus veterans who received the drug. He called it a "bogus study" and said he was "clearly not a friend of the administration" who "wanted to make a political point."

The president made similar remarks earlier on Tuesday, referring to an unspecified "poor turnout" that was "a statement by Trump's enemy." On Monday, he said the VA study was "done by people who are not big Trump fans."

He also complained on Tuesday that the drug was given to people who were "old" and "ready to die."

Facts First: There is no clear basis for Trump's claims that the Veterans study was designed to hurt him. While there are legitimate criticisms of the study, which was small, retrospective, focusing on critically ill patients, not peer-reviewed nor randomized or controlled, Trump made his claims of some sort of political conspiracy No evidence is given. The authors of the study clearly believed that it had significant limitations. Large, peer-reviewed studies have also concluded that hydroxychloroquine did not benefit coronavirus patients.

The VA study conducted by researchers at the University of South Carolina, the University of Virginia, and the Dorn Research Institute in South Carolina analyzed the medical data of 368 male patients at the Veteran Health Center, 97 patients who took hydroxychloroquine. , 113 who took hydroxychloroquine and the antibiotic azithromycin, and 158 patients did not. Patients taking hydroxychloroquine alone had a mortality rate of 27.8%, while those who did not take the drug had a mortality rate of 11.4%. The study also found that patients taking the drug were less likely to require mechanical ventilation.

The study was published on the Medicarex Medical website, not a peer-reviewed journal. Secretary of Veterans Affairs Robert Wilkie said the study noted "a small number of experienced people" in "later stages of life". VA spokesman Christine Noel told NBC that hydroxychloroquine was "provided to the sickest Covid-19 patients in the VA, often as a last resort."

Professor of Medicine at Univ. William Scheffner said, "It is possible that sick patients receive more medication than those who are less ill, and so these retrospective studies are a guide, but they are not definitive." Wonderbuilt and infectious disease specialist. Illness, he told CNN on Tuesday after Trump's comments, "requires more careful study."

Study authors, who did not respond to CNN requests for comment, effectively wrote in the study itself: "These findings highlight the importance of waiting for the results of ongoing, randomized controlled studies before widespread adoption" . Of these drugs. "He also openly discussed the specific limitations of his study. For example, he wrote that since they were looking at a group of mostly black men over the age of 65 on average, their findings may not apply to women, younger people, and other groups.

Several randomized controlled trials are being conducted in the United States. In the US and elsewhere more specifically determine the effectiveness of hydroxychloroquine for coronovirus. (The drug is already approved by the FDA for use against malaria, lupus, and rheumatoid arthritis.) However, it is worth noting that the study of veterans was not the only study to date that has been used for coronovirus treatment Hydroxychloroquine was not found to be effective.

A University of Albany study of 1,438 coronavirus patients in 25 hospitals in the New York City area, published in the Journal of the American Medical Association, found hydroxychloroquine (or hydroxychloroquine plus azithromycin) and those who did not, also found that patients taking the drug combination in the study During the period, the chances of experiencing cardiac arrest were double.

A study at Columbia University by Columbia University's Presbyterian Hospital and Irving Medical Center and published in the New England Journal of Medicine evaluated 1,376 consecutive patients, with no better results with hydroxychloroquine.

Trump's former VA secretary David Shulkin said on Twitter after the president's statements on Tuesday, "The risks of taking hydroxychloroquine are real, however, there is no data to show that it is effective for COViD19. That's why it It alone is now to be used in ongoing clinical trials. I am concerned that the precedent is set and if other medication may be taken improperly. "

Post a Comment

0 Comments